Godshalk Welsh Capital Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-11,200
| Closed | -$893K | – | 121 |
|
|
2024
Q1 | $893K | Buy |
11,200
+50
| +0.4% | +$3.82K | 0.6% | 56 |
|
|
2023
Q4 | $880K | Hold |
11,150
| – | – | 0.63% | 56 |
|
|
2023
Q3 | $778K | Sell |
11,150
-1,200
| -10% | -$85K | 0.59% | 61 |
|
|
2023
Q2 | $854K | Hold |
12,350
| – | – | 0.59% | 59 |
|
|
2023
Q1 | $918K | Buy |
12,350
+50
| +0.4% | +$4.19K | 0.65% | 53 |
|
|
2022
Q4 | $1.15M | Sell |
12,300
-430
| -3% | -$41.5K | 0.84% | 45 |
|
|
2022
Q3 | $1.21M | Buy |
12,730
+180
| +1% | +$17.8K | 0.9% | 45 |
|
|
2022
Q2 | $1.16M | Hold |
12,550
| – | – | 0.84% | 45 |
|
|
2022
Q1 | $1.27M | Sell |
12,550
-200
| -2% | -$21K | 0.78% | 46 |
|
|
2021
Q4 | $1.31M | Hold |
12,750
| – | – | 0.75% | 48 |
|
|
2021
Q3 | $1.08M | Hold |
12,750
| – | – | 0.67% | 52 |
|
|
2021
Q2 | $1.05M | Sell |
12,750
-250
| -2% | -$20.5K | 0.65% | 54 |
|
|
2021
Q1 | $978K | Buy |
13,000
+750
| +6% | +$54.6K | 0.68% | 52 |
|
|
2020
Q4 | $837K | Buy |
12,250
+1,025
| +9% | +$66.7K | 0.62% | 57 |
|
|
2020
Q3 | $656K | Buy |
11,225
+375
| +3% | +$23.3K | 0.55% | 62 |
|
|
2020
Q2 | $705K | Sell |
10,850
-150
| -1% | -$9.45K | 0.66% | 58 |
|
|
2020
Q1 | $653K | Sell |
11,000
-225
| -2% | -$15K | 0.71% | 56 |
|
|
2019
Q4 | $834K | Buy |
11,225
+1,670
| +17% | +$117K | 0.69% | 58 |
|
|
2019
Q3 | $603K | Buy |
+9,555
| New | +$566K | 0.53% | 69 |
|
|
2019
Q2 | – | Sell |
-3,956
| Closed | -$213K | – | 108 |
|
|
2019
Q1 | $213K | Hold |
3,956
| – | – | 0.2% | 102 |
|
|
2018
Q4 | $259K | Buy |
3,956
+251
| +7% | +$18.7K | 0.29% | 91 |
|
|
2018
Q3 | $292K | Hold |
3,705
| – | – | 0.28% | 88 |
|
|
2018
Q2 | $238K | Hold |
3,705
| – | – | 0.25% | 98 |
|
|
2018
Q1 | $230K | Hold |
3,705
| – | – | 0.25% | 100 |
|
|
2017
Q4 | $269K | Hold |
3,705
| – | – | 0.27% | 101 |
|
|
2017
Q3 | $301K | Sell |
3,705
-750
| -17% | -$59.3K | 0.3% | 103 |
|
|
2017
Q2 | $358K | Sell |
4,455
-420
| -9% | -$33.2K | 0.36% | 94 |
|
|
2017
Q1 | $383K | Sell |
4,875
-250
| -5% | -$20K | 0.38% | 92 |
|
|
2016
Q4 | $404K | Sell |
5,125
-400
| -7% | -$32.4K | 0.41% | 85 |
|
|
2016
Q3 | $492K | Hold |
5,525
| – | – | 0.51% | 76 |
|
|
2016
Q2 | $529K | Sell |
5,525
-500
| -8% | -$49.8K | 0.56% | 72 |
|
|
2016
Q1 | $625K | Sell |
6,025
-150
| -2% | -$14.6K | 0.65% | 61 |
|
|
2015
Q4 | $604K | Hold |
6,175
| – | – | 0.63% | 61 |
|
|
2015
Q3 | $596K | Hold |
6,175
| – | – | 0.65% | 61 |
|
|
2015
Q2 | $648K | Sell |
6,175
-75
| -1% | -$7.66K | 0.66% | 63 |
|
|
2015
Q1 | $645K | Hold |
6,250
| – | – | 0.66% | 61 |
|
|
2014
Q4 | $602K | Buy |
+6,250
| New | +$551K | 0.55% | 68 |
|
Other funds holding CVS
Godshalk Welsh Capital Management's CVS Position: Q2 2024 in Review
Godshalk Welsh Capital Management sold out of CVS Health (CVS) in Q2 2024, closing a stake of 11,200 shares — an estimated $893K sold.
Godshalk Welsh Capital Management first reported a position in CVS in Q4 2014 and held it in 37 quarters. The position peaked at $1.31M in Q4 2021. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.
- Godshalk Welsh Capital Management reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
- Godshalk Welsh Capital Management sold 11,200 CVS Health shares in Q2 2024, an estimated $893K.
- Godshalk Welsh Capital Management first reported a position in CVS Health in Q4 2014 and held it in 37 quarters.
- Godshalk Welsh Capital Management's CVS Health position peaked at $1.31M in Q4 2021.
- 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.
Based on Godshalk Welsh Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.